Evidence map›Paper›PMID 20663572›Full record

ReviewTrends in neurosciences2010

The molecular and gene regulatory signature of a neuron.

Oliver Hobert, Inés Carrera, Nikolaos Stefanakis

Abstract readReview
In one paragraph

Review in Trends in neurosciences, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed.

  1. Article
  2. CUT homeobox factors modulate chromatin accessibility in neurons.bioRxiv : the preprint server for biology · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. A low affinityeLife · 2020
    Article
  14. Behavior-related gene regulatory networks: A new level of organization in the brain.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Oliver HobertColumbia University Medical Center, Howard Hughes Medical Institute, New York, NY, USA. or38@columbia.edu
Inés Carrera
Nikolaos Stefanakis

Funding

LIM HOMEOBOX GENE LIM-6 IN MOTOR NEURON DIFFERENTIATIONR01NS039996 · NINDS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Oliver Hobert · 2001 to 2026
$6.8M
Genetic analysis of dopaminergic neuron specification in C.elegansR01NS050266 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HOBERT, OLIVER · 2004 to 2013
$3.4M
Howard Hughes Medical InstituteNINDS NIH HHS R01 NS039996NINDS NIH HHS R01NS039996-05NINDS NIH HHS R01 NS050266NINDS NIH HHS R01NS050266-03
6 · The paper itself

Abstract

Neuron-type specific gene batteries define the morphological and functional diversity of cell types in the nervous system. Here, we discuss the composition of neuron-type specific gene batteries and illustrate gene regulatory strategies which determine the unique gene expression profiles and molecular composition of individual neuronal cell types from C. elegans to higher vertebrates. Based on principles learned from prokaryotic gene regulation, we argue that neuronal terminal gene batteries are functionally grouped into parallel-acting 'regulons'. The theoretical concepts discussed here provide testable hypotheses for future experimental analysis of the exact gene-regulatory mechanisms employed in the generation of neuronal diversity and identity.

Indexed as

AnimalsCell DifferentiationGene Expression ProfilingGene Expression RegulationGenes, RegulatorHumansMolecular Sequence DataNeuronsRegulatory Elements, Transcriptional

Identifiers

PMID20663572
PMCPMC2947585

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.